Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Computer-aided drug design: developing and applying simulation-based tools to identify small-molecule ligands that inhibit proteins

Hellemann Holguin, Erich (2023) Computer-aided drug design: developing and applying simulation-based tools to identify small-molecule ligands that inhibit proteins. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

This is the latest version of this item.

[img]
Preview
PDF
Updated Version

Download (10MB) | Preview

Abstract

In this dissertation, I discuss how computational methods can help in drug discovery, from developing a new tool that allows obtaining ensembles of protein conformations to using established computational tools for elucidating the mechanism of inhibition.
Sub-Pocket Explorer (SubPEx) is a tool I wrote that leverages weighted ensemble to accelerate the sampling of protein pocket conformations. I demonstrated that SubPEx is faster and protein pocket conformations are more diverse than those obtained by vanilla molecular dynamics (MD) simulations. I applied the SubPEx algorithm to three relevant proteins for human health: heat shock protein 90, neuraminidase, and hexokinase II. With these proteins, I showed how SubPEx could be applied to small rigid proteins, proteins with a flexible pocket, and proteins that undergo extensive domain rearrangements.
I show how a combination of experimental and computational work can help find a new resistance mechanism to the known inhibitor 2-deoxy-glucose (2DG). I described how collaborators found a new mutation in hexokinase II and how with MD simulations, I proposed a mechanism by which this mutation could confer resistance to 2DG.
Finally, I show the importance of undergraduate research and what we can achieve with the help of undergraduates. In one of the two projects I did with undergraduates, we applied an established computational protocol to recommend small molecule binders to a protein involved in cancer. The last project I described in the dissertation is how we used MD simulations to discover the allosteric mechanism by which a small molecule inhibits TEM-1, a protein involved in multidrug resistance.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Hellemann Holguin, Erichehellemann@pitt.eduerh910000-0002-5565-8614
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairDurrant, Jacob D.durrantj@pitt.edudurrantj
Committee MemberChong, Lillian T.ltchong@pitt.edultchong
Committee MemberKurnikova, Mariakurnikova@cmu.edu
Committee MemberKoes, David R.dkoes@pitt.edudkoes
Date: 25 January 2023
Date Type: Publication
Defense Date: 21 September 2022
Approval Date: 25 January 2023
Submission Date: 31 October 2022
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Number of Pages: 163
Institution: University of Pittsburgh
Schools and Programs: Dietrich School of Arts and Sciences > Molecular Biophysics and Structural Biology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: Computer-aided drug design, Molecular dynamics, Weighted ensemble, docking
Date Deposited: 25 Jan 2023 16:30
Last Modified: 25 Jan 2023 16:30
URI: http://d-scholarship.pitt.edu/id/eprint/43845

Available Versions of this Item

  • Computer-aided drug design: developing and applying simulation-based tools to identify small-molecule ligands that inhibit proteins. (deposited 25 Jan 2023 16:30) [Currently Displayed]

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item